PubIndex
Search
Leaderboards
Bookmark
My Library
Sign in
Back
Cell Signaling Technology
SignalStain® Akt Pathway IHC Sampler Kit
#8107 · $686
100
Citing papers
4.1k
Combined citations
Copy product info
Export PDF dossier
Supplier page
Find this product
Research areas
RNA Research and Splicing
11
RNA modifications and cancer
7
Epigenetics and DNA Methylation
7
MicroRNA in disease regulation
6
Cell death mechanisms and regulation
5
Cancer-related Molecular Pathways
5
Retinoids in leukemia and cellular processes
5
Ubiquitin and proteasome pathways
5
Papers citing this product
1
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
Nature Communications
·
2018
·
227 cit.
·
DOI
2
Tissue- and cell-type–specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model
Proceedings of the National Academy of Sciences
·
2013
·
204 cit.
·
DOI
3
Heat Shock Protein 27 Association with the IκB Kinase Complex Regulates Tumor Necrosis Factor α-induced NF-κB Activation
Journal of Biological Chemistry
·
2003
·
186 cit.
·
DOI
4
Tissue-specific control of brain-enriched miR-7 biogenesis
Genes & Development
·
2013
·
159 cit.
·
DOI
5
Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia
Nature Communications
·
2019
·
146 cit.
·
DOI
6
The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Induces Tumor Regression in a Genetically Engineered Mouse Model of PIK3CA Wild-Type Colorectal Cancer
PLoS ONE
·
2011
·
140 cit.
·
DOI
7
New power of self-assembling carbonic anhydrase inhibitor: Short peptide–constructed nanofibers inspire hypoxic cancer therapy
Science Advances
·
2019
·
137 cit.
·
DOI
8
Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
Nature Communications
·
2015
·
128 cit.
·
DOI
9
Role of Cannabinoid Type 1 Receptors in Locomotor Activity and Striatal Signaling in Response to Psychostimulants
Journal of Neuroscience
·
2007
·
125 cit.
·
DOI
10
LncRNA MT1JP functions as a tumor suppressor by interacting with TIAR to modulate the p53 pathway
Oncotarget
·
2016
·
115 cit.
·
DOI
Show 90 more papers
Feedback